Clinical Trial: Biomarker for Patients With Transthyretin-Related Familial Amyloidotic Polyneuropathy

Study Status: Recruiting
Recruit Status: Recruiting
Study Type: Observational




Official Title: Biomarker for Transthyretin-Related Familial Amyloidotic Polyneuropathy - An International, Multicenter, Epidemiological Protocol

Brief Summary: Development of a new MS-based biomarker for the early and sensitive diagnosis of Transthyretin-Related Familial Amyloidotic Polyneuropathy from plasma. Testing for clinical robustness, specificity and long-term stability of the biomarker.